A single-shot coronavirus vaccine from Johnson & Johnson will be tested in 60,000 people
Three other candidates have a head start, but J&J’s vaccine could be easier to administer and distribute if it is proved safe and effective. Read Article
Three other candidates have a head start, but J&J’s vaccine could be easier to administer and distribute if it is proved safe and effective. Read Article
3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu